Personalized cancer treatment on the way
New Scientist Health, Nov. 19, 2008
IT IS usually impossible to tell whether someone's cancer will
respond to therapy. That could change with the discovery of a genetic
signature that predicts whether a variety of cancers will respond to
the most common treatments. This could help identify which patients
need drugs and radiotherapy, and which can be treated less aggressively
University of Chicago scientists have discovered a genetic signature
that predicts whether a variety of cancers will respond to the most
common treatments: they found that many cancers show abnormalities in
49 specific genes, collectively known as the IFN-related DNA damage
resistance signature (IRDS).
See:
http://www.newscientist.com/article/mg20026824.300-personalised-cancer-treatment-on-the-way.html?